Continuous glucose monitoring systems for type 1 diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2012, Pages

  Langendam, Miranda ^a   Luijf, Yoeri M ^a   Hooft, Lotty ^a   Devries, J Hans ^a   Mudde, Aart H ^b   Scholten, Rob J P M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLINGELAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADVERSE EVENT; BLOOD GLUCOSE MONITORING; CLINICAL OUTCOME; COST CONTROL; DATA EXTRACTION; DEATH; DIABETIC KETOACIDOSIS; DISEASE ASSESSMENT; DISEASE SEVERITY; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME ECHOGRAPHY; REVIEW; RISK FACTOR; SELF MONITORING; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; BLOOD; CHILD; COMPARATIVE STUDY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; QUALITY OF LIFE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862668643     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008101.pub2     Document Type: Review

References (79)

1. Battelino T, Nimri R, Philip M, Oskarsson P, Bratina N, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34(4):795-800.
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of Sensor-Augmented Insulin-Pump Therapyin Type 1 Diabetes. British Medical Journal 2010;363(4):311-20.
3. Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingensmith G, Murtfeldt R, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001;107(2):222-6.
4. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;4:1153-7.
5. Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith A, et al. Randomized controlled trial to assess the impact ofcontinuous glucose monitoring on HbA1c in insulintreateddiabetes (MITRE Study). Diabetic Medicine 2009;26:540-547.
6. Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, Attali J-R, Paris J, Schaepelynck BP. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes & Metabolism 2009;35:312-8.
7. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Experimental and Clinical Endocrinology and Diabetes 2006;2:63-7.
8. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29(12):2730-2.
9. Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Vermon C, Wentholt I, DeVries JH. Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled type 1 diabetes: a randomized controlled trial. Diabetic Medicine 2011;28(10):1158-67.
10. Hermanns N, Kulzer B, Gulde C, Eberle H, Pradler E, Patzelt-Bath A, et al. Short-term effects on patient satisfaction of continuous glucose monitoring with the glucoday with real-time and retrospective access to glucose values: A crossover study. Diabetes Technology and Therapeutics 2009;5:275-81.
11. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, et al. Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. Diabetes Technology and Therapeutics 2008;5:377-83.
12. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. New England Journal of Medicine 2008;359(14):1464-76.
13. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Group. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010;33:2175-2177.
14. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32(8):1378-81.
15. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, et al. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Pediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010;53(12):2487-95.
16. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: A single-blind, randomized, controlled trial. Pediatric Diabetes 2006;3:159-64.
17. Logtenberg SJJ, Kleefstra N, Groenier KH, Gans ROB, Bilo HJG. Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: A feasibility study. Diabetes Technology and Therapeutics 2009;5:293-9.
18. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: A controlled crossover study. Pediatrics 2003;5:933-8.
19. O'Connell MA, Donath D, O'Neal DN, Colman P, Ambler GR, Jones TW, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009;52:1250-7.
20. Peyrot M, Rubin RR. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technology & Therapeutics 2009;11(1):57-62.
21. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire-Broutin H, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The RealTrend study. Diabetes Care 2009;32:2245-50.
22. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clinic Proceedings 2004;79(12):1521-6.
23. Yates K, Milton AH, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: A randomized controlled trial. Diabetes Care 2006;7:1512-7.
24. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, et al. Alarms Based on Real-Time Sensor Glucose Values Alert Patients to Hypo- and Hyperglycemia: The Guardian Continuous Monitoring System. Diabetes Technology and Therapeutics 2004;2:105-13.
25. Bode B, Shelmet J, Gooch B, Hassman DR, Liang J, Smedegaard JK, et al. Patient perception and use of an insulin injector/glucose monitor combined device. Diabetes Educator 2004;30(2):301-9.
26. Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003;4:790-4.
27. Chase HP. A randomized multicenter trial comparing the glucowatch biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;5:1101-6.
28. Feldman B, Brazg R, Schwartz S, Weinstein R. A Continuous Glucose Sensor Based on Wired Enzyme[trademark] Technology - Results from a 3-Day Trial in Patients with Type 1 Diabetes. Diabetes Technology and Therapeutics 2003;5:769-79.
29. Fiallo-Scharer R. Eight-point glucose testing Versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2005;6:3387-91.
30. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: A randomized controlled trial. Diabetes Care 2006;1:44-50.
31. Garg SK, Bookout TR, Mcfann KK, Kelly WC, Beatson C, Ellis SL, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technology & Therapeutics 2008;10(5):369-75.
32. Haupt A, Berg B, Paschen P, Dreyer M, Haring HU, Smedegaard J, et al. InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference. Experimental & Clinical Endocrinology & Diabetes 2005;113(9):541-4.
33. Jeha GS, Karaviti LP, Anderson B, Smith EO'B, Donaldson S, Mcgirk TS, et al. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 2004;12:2881-6.
34. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Sustained benefit of continuous glucose monitoring and HbA1c, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009;32(11):2047-9.
35. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: Randomised clinical trial. British Medical Journal 2008;7675:907-10.
36. Rowen M, Schneider DJ, Pratley RE, Sobel BE. On rendering continuous glucose monitoring ready for prime time in the cardiac care unit. Coronary Artery Disease 2007;18(5):405-9.
37. Tamborlane WV, Ruedy KJ, Wysocki T, O'Grady M, Kollman C, Block J, et al. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods. Diabetes Technology and Therapeutics 2008;4:310-21.
38. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, et al. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: Results of a pilot trial diabetes research in children network (DirecNet) study group. Diabetes Care 2008;3:525-7.
39. Wilhelm B, Forst S, Weber MM, Larbig M, Pfutzner A, Forst T. Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetes. Diabetes Technology and Therapeutics 2006;2:146-55.
40. Wysocki T. Youth and parent satisfaction with clinical use of the glucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005;8:1929-35.
41. Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies - A pilot study. Diabetic Medicine 2003;7:558-62.
42. Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstetrics and Gynecology 2003;4:633-8.
43. Conget I, Battelino T, Gimenez M, Gough H, Castaseda J, Bolinder J. The SWITCH study (Sensing with insulin pump therapy to control HbA1c). Design and methods of a randomized controlled cross-over trial on sensor-augmented insulin pump efficacy in type 1 diabetes sub-optimally controlled with pump therapy. Diabetes Technology and Therapeutics 2011;13(1):49-54.
44. Lange K, Coutant R, Danne T, Kapellen T, Pankowska, Rami B, Aschemeier B, Blsig S, Hartmann R, Krug N, Marquardt E, Remus K, Kordonouri O. High quality of life in children and psychological wellbeing in mothers 12 months after diabetes onset: results of the paediatric onset-trial of sensor-enhanced CSII. Pediatric Diabetes 2010;11(Suppl s14):101.
45. Langeland LL, Salvesen O, Selle H, Carlsen SM, Fougner KJ. Continuous glucose monitoring: effect on glucose control and treatment satisfaction in diabetes mellitus type 1. Diabetologica 2010;53(Supplement 1):S423.
46. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22 Suppl 1:S5-19.
47. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-62.
48. Bradburn MJ, Deeks JJ, Berlin JA, Russell LA. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statistics in Medicine 2007;26:53-77.
49. Bradley C. The Well-being Questionnaire. In: Bradley C editor(s). Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Harwood Academic Publishers, 1994:89-109.
50. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Bradley C editor(s). Handbook of Psychology and Diabetes. Harwood Academic Publishers, 1994:111-32.
51. Brauker J. Continuous glucose sensing: future technology developments. Diabetes Technology & Therapeutics 2009;11(s1):s25-s36.
52. Chetty VT, Almulla A, Odueyungbo A, Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Research and Clinical Practice 2008;81:79-87.
53. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
54. Cryer PE. Diverse causes of hypoglycaemia-associated autonomic failure in diabetes. New England Journal of Medicine 2004;350:2272-9.
55. DCCT Research Group. The diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993;329(14):977-86.
56. US Food, Drug Administration. Guidance for Industry. Diabetes Mellitus: developing drugs and therapeutic biologics for treatment and prevention (Draft guidance). US Food and Drug Administration 2009.
57. Ghandi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Safwan Murad M, Erwin PJ, Corpus J, Montori VM, Murad MH. Efficacy of continuous glucose monitoring in improving glycaemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. Journal of Diabetes Science and Technology 2011;5(4):952-965.
58. Girardin CM, Huot C, Gonthier M, Delvin E. Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. Clinical Biochemistry 2009;42:136-142.
59. Golicki DT, Golicka D, Groele L, Pankowska E. Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologica 2008;51:233-40.
60. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Medicine 1994;11(3):253-61.
61. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. British Medical Journal 2003;327:557-60.
62. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
63. Hoeks LBEA, Greven WL, De Valk HW. Review Article: Real-time continuous glucose monitoring system fortreatment of diabetes: a systematic review. Diabetic Medicine 2010;doi: 10.1111/j.1464-5491.2010.03177.x:In press.
64. Klonoff DC. Continuous glucose monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care 2005;28:1231-9.
65. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. British Medical Journal 2006;333:597-600.
66. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA Statement for Reporting Systematic and Meta-Analyses of Studies That Evaluate Interventions: Explanation and Elaboration. PLoS Med 1999;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
67. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 1993;31(3):247-63.
68. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine 2005;353(25):2643-53.
69. National Collaborating Centre for Women's and Children's Health. Type 1 diabetes diagnosis and management of type 1 diabetes in children and young people. London: RCOG Press, 2004.
70. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. British Medical Journal 2011;343:d3805.
71. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
72. Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London: BMJ Publishing Group, 2001:189-208.
73. Thierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer K, Ackerman NR, Fermi SJ. The GlucoWatch Biographer: a frequent, automatic and noninvasive glucose monitor. Annals in Medicine 2000;32:641.
74. Wentholt IM, Vollebregt MA, Hart AA, Hoekstra JB, De Vries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care 2005;28(12):2871-6.
75. Wentholt IME, Hoekstra JBL, De Vries JH. Continuous glucose monitors: the long awaited watch dogs?. Diabetes Technology & Therapeutics 2007;9(5):399-409.
76. Wentholt IM, Hart AA, Hoekstra JB, De Vries JH. How to assess and compare the accuracy of continuous glucose monitors?. Diabetes Technol Ther 2008;10(2):57-68.
77. WHO Expert Committee on Diabetes Mellitus. Second report. Technical Report Series 646. Geneva. WHO, 1980.
78. WHO Expert Committee on Diabetes Mellitus. World Health Organization, 1985. Technical Report Series 727.
79. Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539-53.